Agios Pharma(DE:8AP)
€28.40+1.20 (+4.41%)
DE:8AP
Agios Pharma earnings date
€28.40
At close:+1.20 (+4.41%)
Agios Pharma (8AP) Q2 2023 Earnings Report
0 Followers
DE:8AP Q2 2023 EPS Results
- Actual EPS
- -EUR 1.35
- Consensus EPS
- -EUR 1.40
- Beat/Miss
- Beat by +EUR 0.05
- One Year Ago EPS
- -EUR 1.50
DE:8AP Q2 2023 Revenue Results
- Actual Revenue
- EUR 6.01M
- Expected Revenue
- EUR 5.79M
- Beat/Miss
- Beat by +EUR 222.94K
- YoY Revenue Growth
- +20.24%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/03/2023
- Time
- Before Open
- Conference Call
- Thursday, August 3, 2023
DE:8AP Upcoming Earnings
Agios Pharma's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
DE:8AP Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:8AP Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | -0.98- | -1.67 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -1.11-0.98 | -1.59 | 38.76% (+0.62) | |
| Jul 30, 2026 | 2026 (Q2) | -1.48-1.51 | -1.73 | 12.44% (+0.21) | |
| Apr 29, 2026 | 2026 (Q1) | -1.61-1.51 | -1.39 | -9.03% (-0.13) | |
| Feb 12, 2026 | 2025 (Q4) | -1.75-1.67 | -1.29 | -29.17% (-0.38) | |
| Oct 30, 2025 | 2025 (Q3) | -1.70-1.59 | 14.52 | -110.97% (-16.12) | |
| Jul 31, 2025 | 2025 (Q2) | -1.62-1.73 | -1.51 | -14.20% (-0.21) | |
| May 01, 2025 | 2025 (Q1) | -1.59-1.39 | -1.3 | -6.90% (-0.09) | |
| Feb 13, 2025 | 2024 (Q4) | -1.51-1.29 | -1.53 | 15.79% (+0.24) | |
| Oct 31, 2024 | 2024 (Q3) | 13.6214.52 | -1.47 | 1089.02% (+15.99) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
